Estela M.F. Muri - Concepedia

Author

Estela M.F. Muri

Also Known As

E. M. F. MURI, E. M. F. Muri, E. Muri, E.M.F. Muri, ESTELA M.F. MURI, Estela M.F. Muri, Estela F. MURI, Estela M. F. Muri, Estela M.F. Muri, Estela Maris F. Muri

Publications

955

Citations

H-Index

Concepts

All Affiliations

Universidade Federal Fluminense Universidade Federal do Rio de Janeiro Universidade Federal do ABC University of Mississippi Université Joseph Fourier

About

Estela M.F. Muri is an author at Universidade Federal Fluminense specializing in pharmacology, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	12	14	379
2	Medicine	11	13	372
3	Biochemistry	11	12	332
4	Engineering	3	3	41
5	Biomolecular Engineering	2	2	22

Estela M.F. Muri

Publications

567

Citations

H-Index

Page 1

	Year	Citations
3-Acyltetramic acids as a novel class of inhibitors for human kallikreins 5 and 7 Acácio S. de Souza, Barbara D.C. Pacheco, Sérgio Pinheiro, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceBiochemistryHuman Kallikreins 5	2019	59
Biological activities of [1,2,4]triazolo[1,5-a]pyrimidines and analogs Sérgio Pinheiro, Erick M.C. Pinheiro, Estela M.F. Muri, Medicinal Chemistry Research Combinatorial ChemistryBioorganic ChemistryBiochemistryAntiparasitic AgentMedicine	2020	48
Viral proteases: important targets of peptidemimetic compounds. Estela M.F. Muri Química Nova	2014	46
Biological evaluation and molecular modeling of peptidomimetic compounds as inhibitors for O-GlcNAc transferase (OGT) Suraby O. Albuquerque, Thalita G. Barros, Luiza R.S. Dias, European Journal of Pharmaceutical Sciences Inhibitory ActivityMedicinal ChemistryBioorganic ChemistryBiochemistryMedicine	2020	46
Design and Synthesis of Heterocyclic Hydroxamic Acid Derivatives as Inhibitors of<i>Helicobacter</i><i>pylori</i>Urease Estela M.F. Muri, Hetal Mishra, Mitchell A. Avery, Synthetic Communications Medicinal ChemistryBiochemistryMedicineNatural SciencesH. Pylori	2003	35
Isomannide-Based Peptidomimetics as Inhibitors for Human Tissue Kallikreins 5 and 7 Jocélia P. C. Oliveira, Renato Ferreira de Freitas, Leandro Silva de Melo, ACS Medicinal Chemistry Letters Pharmaceutical ScienceDrug TargetPeptide ScienceIsomannide-based PeptidomimeticsPharmaceutical Chemistry	2013	34
Synthesis and mechanistic evaluation of novel N ’-benzylidene-carbohydrazide-1 H -pyrazolo[3,4 -b ]pyridine derivatives as non-anionic antiplatelet agents André Luiz Lourenço, Raquel Rocha Silva Salvador, Leonardo A. Silva, European Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryDerivativesDerivative (Chemistry)Natural Sciences	2017	27
Isomannide derivatives as new class of inhibitors for human kallikrein 7 Renato Ferreira de Freitas, Thiago Salem Pançonato Teixeira, Thalita G. Barros, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryPharmaceutical ScienceDerivative (Chemistry)	2012	25
Trypanocidal activity of new 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine derivatives: Synthesis, in vitro and in vivo studies Joana Lucius de Sousa Ribeiro, Júlio C. A. V. Soares, Gisele Bulhões Portapilla, Bioorganic & Medicinal Chemistry Trypanocidal ActivityVivo StudiesAntiparasitic AgentMedicineAfrican Trypanosomiasis	2020	24
Hydroxamic Acids Designed as Inhibitors of Urease Thalita G. Barros, J. Williamson, O. A. C. Antunes, Letters in Drug Design & Discovery	2009	23

Page 1